Q3 2020 Holdings
Filed 2020-11-13 | 135 holdings | $10.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $3.3M | 37,769 | 31.8% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $2.0M | 134,600 | 19.1% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.8M | 99,493 | 17.5% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | Common | 09058V103 | $1.4M | 397,361 | 13.1% |
| Collegium Pharmaceutical, Inc.(COLL) | Common | 19459J104 | $622.0K | 29,862 | 6.0% |
| Corteva Inc.(CTVA) | Common | 22052L104 | $361.0K | 12,545 | 3.5% |
| Cytokinetics, Incorporated(CYTK) | Common | 23282W605 | $343.0K | 15,837 | 3.3% |
| Adma Biologics, Inc.(ADMA) | Common | 000899104 | $156.0K | 65,157 | 1.5% |
| ALX Oncology. Inc(ALXO) | Common | 00166B105 | $113.0K | 3,000 | 1.1% |
| Cousins Properties(CUZ) | Common | 222795502 | $96.0K | 3,357 | 0.9% |
| Cardiff Oncology, Inc.(CRDF) | Common | 14147L108 | $71.0K | 5,000 | 0.7% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $23.6K | 248,041 | 0.2% |
| Upland Software, Inc.(UPLD) | Common | 91544A109 | $15.3K | 406,500 | 0.1% |
| Apollo Global Management, Inc.(APOEUR) | Common | 03768E105 | $13.4K | 300,000 | 0.1% |
| Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | $12.0K | 700,000 | 0.1% |
| Stericycle, Inc.(SRCLEUR) | Common | 858912108 | $10.1K | 160,000 | 0.1% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $8.2K | 5,600 | 0.1% |
| FS KKR Capital Corp.(FSICUSD) | Common | 302635107 | $6.3K | 395,175 | 0.1% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $5.2K | 2,020,000 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $4.8K | 131,900 | 0.0% |
| LKQ Corporation(LKQ) | Common | 501889208 | $4.2K | 150,000 | 0.0% |
| KKR & Co. Inc.(KKR) | Common | 48251W104 | $3.4K | 100,000 | 0.0% |
| Kennedy-Wilson Holdings, Inc.(KW) | Common | 489398107 | $3.0K | 210,000 | 0.0% |
| Horizon Therapeutics Public Ltd. Company | Common | G46188101 | $2.9K | 37,531 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $2.8K | 46,409 | 0.0% |
| Trillium Therapeutics Inc. | Common | 89620X506 | $2.5K | 176,215 | 0.0% |
| Kadmon Holdings, Inc.(KDMN) | Common | 48283N106 | $2.4K | 612,000 | 0.0% |
| Eiger BioPharmaceuticals, Inc.(CLDNEUR) | Common | 28249U105 | $2.2K | 275,348 | 0.0% |
| JP Morgan Chase(JPM) | Common | 46625H100 | $2.2K | 23,050 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $2.0K | 112,707 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $2.0K | 177,000 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $1.8K | 481,930 | 0.0% |
| Mplx LP(MPLX) | Common | 55336V100 | $1.6K | 100,000 | 0.0% |
| Vapotherm, Inc. | Common | 922107107 | $1.4K | 49,000 | 0.0% |
| Alexion Pharamaceuticals, Inc.(ALXN) | Common | 015351109 | $1.4K | 12,000 | 0.0% |
| AllianceBernstein Holding PL Unit Ltd.(AB) | Common | 01881G106 | $1.4K | 50,500 | 0.0% |
| TG Therapeutics Inc.(TGTX) | Common | 88322Q108 | $1.4K | 50,773 | 0.0% |
| Viking Therapeutics, Inc.(VKTX) | Common | 92686J106 | $1.3K | 218,102 | 0.0% |
| Midwest Holding Inc. | Common | 59833J206 | $1.2K | 83,344 | 0.0% |
| International Gaming Technologies(BRSL) | Common | G4863A108 | $1.2K | 107,500 | 0.0% |
| Cidara Therapeutics, Inc. | Common | 171757107 | $1.2K | 407,061 | 0.0% |
| uniQure N.V.(QURE) | Common | N90064101 | $1.1K | 31,000 | 0.0% |
| Verizon Communications Inc.(VZ) | Common | 92343V104 | $1.1K | 18,311 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $1.1K | 7,280 | 0.0% |
| Mondelez Int'l Inc.(MDLZ) | Common | 609207105 | $914 | 15,900 | 0.0% |
| Kimberly Clark Corporation(KMB) | Common | 494368103 | $886 | 6,000 | 0.0% |
| FibroGen, Inc.(FGENEUR) | Common | 31572Q808 | $811 | 19,715 | 0.0% |
| Strongbridge Biopharma PLC | Common | G85347105 | $781 | 372,000 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $695 | 11,000 | 0.0% |
| Dupont De Nemours Inc.(DD) | Common | 26614N102 | $672 | 12,118 | 0.0% |